FDA Drug recall D-1273-2019
Carvedilol Tablets, USP, 6.25 mg, 500 count bottles, Rx Only Manufactured by: Cadila Healthcare Ltd., India Distributed by: Zydus Pharmaceu…
- FDA Drug
- Class II
- terminated
- Published 2019-05-15
On 2019-05-15 the FDA classified a Class II recall of Carvedilol Tablets, USP, 6.25 mg, 500 count bottles, Rx Only Manufactured by: Cadila Healthcare Ltd., India Distributed by: Zydus Pharmaceu… by Zydus Pharmaceuticals Usa, citing labeling; Label Mix-up; report received of one bottle labeled as Acyclovir Tablets USP 400 mg actually contained Carvedilol Tablets 6.25 mg.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1273-2019 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2019-04-25 |
| Published | 2019-05-15 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Zydus Pharmaceuticals Usa |
| Distribution | US |
Product
Carvedilol Tablets, USP, 6.25 mg, 500 count bottles, Rx Only Manufactured by: Cadila Healthcare Ltd., India Distributed by: Zydus Pharmaceuticals (USA) Inc. Pennington, NJ USA 08534 NDC 68382-093-05
Reason
Labeling; Label Mix-up; report received of one bottle labeled as Acyclovir Tablets USP 400 mg actually contained Carvedilol Tablets 6.25 mg
Identifiers
| ndc | 68382-092-17 |
|---|---|
| ndc | 68382-092-01 |
| ndc | 68382-092-05 |
| ndc | 68382-093-17 |
| ndc | 68382-093-05 |
| ndc | 68382-093-01 |
| ndc | 68382-094-17 |
| ndc | 68382-094-01 |
| ndc | 68382-094-05 |
| ndc | 68382-095-17 |
| ndc | 68382-095-01 |
| ndc | 68382-095-05 |
| code_info | Z804517, exp Nov 30, 2020 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1273-2019%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.